Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.5K
1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

6.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
1.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large reasoning models as thinking machines for medicine.

Nature biomedical engineering·2026
Same author

Noninvasive, Rapid, and Precise Identification of Esophageal Cancer via Salivary Extracellular Vesicle-Based Diagnosis.

ACS nano·2026
Same author

Elucidating the functional dynamics of DNASE1L2 intron retention in tuberculosis progression.

Chinese medical journal·2026
Same author

A Mechanophenotyping chip for high-throughput detection of metastatic bacteria-infected circulating tumor cells.

Nature communications·2026
Same author

Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma.

Scientific reports·2026
Same author

Engineered Virus-Like Nanoparticles Enable Multimodal Protein Degradation for Enhanced Tumor Therapy.

Advanced materials (Deerfield Beach, Fla.)·2025
Same journal

Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78.

Theranostics·2026
Same journal

Ion-Responsive Microneedles Delivering Subtype-Specific Mitochondrial Extracellular Vesicles from HEY1⁺ Cardiomyocytes for Cardiac Repair in Bama Minipigs with Myocardial Ischemia-Reperfusion Injury.

Theranostics·2026
Same journal

Mechano-immune interactions in musculoskeletal aging: Mechanisms and translational perspectives.

Theranostics·2026
Same journal

Peripheral blood immune profiling reveals key signatures in newly diagnosed NK/T cell lymphoma patients.

Theranostics·2026
Same journal

Sonogenetics for precision medicine: from molecular toolkit to clinical translation.

Theranostics·2026
Same journal

Programmable pH-responsive DNA inter-strand matching (PRISM) for precision molecular band-pass actuation.

Theranostics·2026
See all related articles

Related Experiment Video

Updated: Apr 23, 2026

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
10:25

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

2.3K

Multidisciplinary efforts driving translational theranostics.

Tony Y Hu1

  • 11. Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030 ; 2. Department of Cell and Developmental Biology, Weill Cornell Medical College of Cornell University, New York, New York 10021.

Theranostics
|October 7, 2014
PubMed
Summary
This summary is machine-generated.

This research explores using biological language to identify "friends" and "foes" in theranostics for clinical use. Success relies on multidisciplinary collaboration to understand host responses and personalize therapies.

Keywords:
RNA interferencebioinformaticsgene deliveryproteomicstheranostics

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 23, 2026

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
10:25

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning

Published on: April 12, 2024

2.3K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research
09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

1.4K

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Clinical Medicine

Background:

  • Theranostics combines therapeutics and diagnostics for personalized medicine.
  • Understanding host responses to theranostic agents is crucial for clinical success.

Discussion:

  • Biological language offers a novel approach to differentiate between beneficial and harmful interactions in theranostics.
  • Multidisciplinary efforts are essential to integrate diverse knowledge for advancing theranostic applications.

Key Insights:

  • Identifying "friends" (beneficial interactions) and "foes" (adverse responses) using biological language is key for effective theranostics.
  • Customized theranostic agents require a deep understanding of host-agent interactions.

Outlook:

  • Future theranostics will likely involve "biological language" interpretation for tailored patient treatments.
  • Individualized therapies based on host responses will enhance theranostic efficacy and safety.